Nasdaq · Healthcare
Personalis, Inc. (PSNL)
As-reported financials and recent SEC filings for Personalis, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$69.6M
Net income
$-81.3M
Net margin
-116.7%
Diluted EPS
$-0.91
ROE
-31.1%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $69.6M | $84.6M | $73.5M | $65.0M | $85.5M |
| Gross profit | $15.8M | $26.8M | $18.2M | $13.3M | $31.7M |
| Operating income | $-88.1M | $-68.3M | $-109.9M | $-115.5M | $-65.4M |
| Net income | $-81.3M | $-81.3M | $-108.3M | $-113.3M | $-65.2M |
| Diluted EPS | $-0.91 | $-1.37 | $-2.25 | $-2.48 | $-1.49 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
1442026-06-29
View on EDGAR →42026-06-29
View on EDGAR →1442026-06-26
View on EDGAR →1442026-06-26
View on EDGAR →42026-06-26
View on EDGAR →42026-06-26
View on EDGAR →4/A2026-06-11
View on EDGAR →SCHEDULE 13D/A2026-06-10
View on EDGAR →Largest Healthcare peers
Go deeper on PSNL
Search Personalis, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.